STOCK TITAN
  1. Home
  2. Sec-filings
  3. HNGE
  4. [Form 4] Hinge Health, Inc. Insider Trading Activity

[Form 4] Hinge Health, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hinge Health, Inc. reported an insider-related share sale involving a major shareholder. A director and 10% owner filed to report sales made by affiliated Bessemer venture funds on December 5, 2025. Bessemer Venture Partners X L.P. sold 2,614 shares of Class A common stock and Bessemer Venture Partners X Institutional L.P. sold 2,453 shares at a weighted average price of $50.0166, in multiple trades between $50.00 and $50.12. The reporting person is a partner at Bessemer Venture Partners and describes only an indirect, passive economic interest in these fund-held shares, formally disclaiming beneficial ownership beyond any pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Robinson Elliott
Role Director, 10% Owner
Sold 0 shs ($0.00)
Type Security Shares Price Value
Sale Class A Common Stock 0 $0.00 --
Holdings After Transaction: Class A Common Stock — 0 shares (Indirect, See footnote)
Footnotes (1)
  1. On December 5, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 2,614 and 2,453 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $50.0166. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.12. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Robinson Elliott
(Last) (First) (Middle)
C/O BESSEMER VENTURE PARTNERS
1865 PALMER AVENUE, SUITE 104
(Street)
LARCHMONT NY 10538
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 12/05/2025 S 0(1) D $0 0 I See footnote(1)(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On December 5, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 2,614 and 2,453 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $50.0166. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.12. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.
/s/ Augie Wilkinson, Attorney-in-Fact 12/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Hinge Health (HNGE) disclose in this Form 4?

The filing reports that Bessemer Venture Partners X L.P. sold 2,614 shares and Bessemer Venture Partners X Institutional L.P. sold 2,453 shares of Hinge Health Class A common stock on December 5, 2025.

At what prices were the Hinge Health (HNGE) shares sold by the Bessemer funds?

The Bessemer funds’ Hinge Health Class A shares were sold at a weighted average price of $50.0166, through multiple trades at prices ranging from $50.00 to $50.12.

What is the reporting person’s relationship to Hinge Health (HNGE)?

The reporting person is identified as both a director of Hinge Health, Inc. and a 10% owner, and is a partner at Bessemer Venture Partners.

Does the reporting person directly own the Hinge Health (HNGE) shares sold in this transaction?

No. The filing explains that the shares are held by Bessemer venture funds, and the reporting person states that he has only an indirect, passive economic interest through partnership interests.

Does the reporting person claim beneficial ownership of the Bessemer funds’ Hinge Health (HNGE) shares?

The reporting person disclaims beneficial ownership of the securities held by the Bessemer funds, except to the extent of any pecuniary interest through his indirect interests in those funds.

How many Hinge Health (HNGE) shares does the Form 4 show as beneficially owned after the reported transaction?

In Table I, the number of Class A common shares beneficially owned following the reported transaction is listed as 0, reported with indirect ownership and explained by the footnotes.